PGx News

<< First  < Prev   1   2   Next >  Last >> 
  • Sun, May 16, 2021 2:59 PM | Sheilah Jewart (Administrator)

    Pharmacogenetic Testing in Healthy Individuals
    Due: Oct 10, 2021
    Contact: daria.dou@mdpi.com

    Information: https://www.mdpi.com/journal/jpm/special_issues/pharmacogenetic_individuals

  • Sun, May 16, 2021 2:55 PM | Sheilah Jewart (Administrator)

    Pharmacogenetics of Treating Anxiety & Depression

    Due Date: Sept 15, 2021
    Contact: Laura.ramsey@cchmc.org

    https://www.mdpi.com/journal/jpm/special_issues/Pharmacogenetics_Anxiety

  • Mon, April 19, 2021 12:24 PM | Sheilah Jewart (Administrator)

    Initiative to Maximize Research Education in Genomics:  Diversity Action Plan (R25)
    (
    PAR-16-345): https://grants.nih.gov/grants/guide/pa-files/PAR-19-380.html

  • Mon, April 19, 2021 12:23 PM | Sheilah Jewart (Administrator)

    Advancing Genomic Medicine Research (R21 Clinical Trial Optional) (RFA-HG-20-037)
    https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-20-037.html

  • Fri, April 02, 2021 8:09 AM | Sheilah Jewart (Administrator)
    Link for the special issue of the Journal of Personalized Medicine focused on PGx of anxiety and depression that I am guest editing:https://www.mdpi.com/journal/jpm/special_issues/Pharmacogenetics_Anxiety

  • Fri, April 02, 2021 8:08 AM | Sheilah Jewart (Administrator)

    Here’s the call for the next special issue of CPT on real world evidence (July 15 deadline):https://www.ascpt.org/Resources/ASCPT-News/View/ArticleId/26736/Real-World-Evidence

  • Sun, December 13, 2020 2:43 PM | Sheilah Jewart (Administrator)

    Deadline: January 01, 2021
    Link

  • Sun, December 13, 2020 2:41 PM | Sheilah Jewart (Administrator)

    Deadline: Feb 02, 2021
    PGx of Adverse Drug Reactions
    Link

  • Sun, December 13, 2020 2:38 PM | Sheilah Jewart (Administrator)

    Due date: April 01, 2021
    Special Issue of CPT: Pharmacogenetics & Pharmacogenomics
    Link

  • Sun, December 06, 2020 2:42 PM | Sheilah Jewart (Administrator)

    Charlie Paulding, PhD, representing PGRN, will be a speaker at the "Polygenic Risk Scores: Current Status and Future Utility" virtual conference being held Wed Feb 17.  Information

<< First  < Prev   1   2   Next >  Last >> 


Copyright © 2020 the Pharmacogenomics Global Research Network. All Rights Reserved.

Follow us on


Become a Member

PGRN logo
Membership dues are vital to continue the mission and work of the PGRN. Founding Members will be listed on the PGRN website. 
Powered by Wild Apricot Membership Software